Aclarion Inc
For the period ended Dec 31, 2023. Filed Mar 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 28, 2024
ACON$1.75+5.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Power of Attorney
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on the 28th day of March, 2024.
| /s/ Jeffrey Thramann | Executive Chairman and Director |
|---|---|
| Jeffrey Thramann, M.D. | |
| /s/ Brent Ness | President, Chief Executive Officer and Director |
| Brent Ness | (Principal Executive Officer) |
| /s/ John Lorbiecki | Chief Financial Officer |
| John Lorbiecki | (Principal Financial and Accounting Officer) |
| /s/ Stephen Deitsch | Director |
| Stephen Deitsch | |
| /s/ David Neal | Director |
| David Neal | |
| /s/ Amanda Williams | Director |
| Amanda Williams | |
| /s/ Scott Breidbart | Director |
| Scott Breidbart, M.D. | |
| /s/ William Wesemann | Director |
| William Wesemann | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.